Prostate Cancer Clinical Trial

Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer

Summary

The purpose of this research study is to compare profiles in the blood and tears of patients with and without prostate cancer with the goal of developing a method of separating men with aggressive and non-aggressive disease.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male, 35-85 years old
Patients who present for the evaluation of an abnormal exam or test (elevated PSA, abnormal DRE, etc.)
Patients who present for the evaluation of a palpable nodule or induration on prostate exam
Patients who meet the requirements of Group 1, 2, or 3 of the protocol

Exclusion Criteria:

Patient < 35 or > 85 years of age
Concurrent eye infection or trauma, including active conjunctivitis
Abnormal production of tears (too much or too little)
Any other conditions the PI or staff feels will not fulfill the criteria for study entry or will place the subject in a harmful environment
Atypia on prostate biopsy report

Study is for people with:

Prostate Cancer

Estimated Enrollment:

75

Study ID:

NCT01514669

Recruitment Status:

Active, not recruiting

Sponsor:

University of Arkansas

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Arkansas for Medical Sciences
Little Rock Arkansas, 72205, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

75

Study ID:

NCT01514669

Recruitment Status:

Active, not recruiting

Sponsor:


University of Arkansas

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.